These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18843023)

  • 41. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
    Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
    Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A polymorphism in the APE1 gene promoter is associated with lung cancer risk.
    Lo YL; Jou YS; Hsiao CF; Chang GC; Tsai YH; Su WC; Chen KY; Chen YM; Huang MS; Hu CY; Chen CJ; Hsiung CA
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):223-9. PubMed ID: 19124501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor necrosis factor alpha extended haplotypes and risk of gastric carcinoma.
    Canedo P; Durães C; Pereira F; Regalo G; Lunet N; Barros H; Carneiro F; Seruca R; Rocha J; Machado JC
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2416-20. PubMed ID: 18768512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysis.
    Zhang Z; Wang S; Wang M; Tong N; Fu G; Zhang Z
    Carcinogenesis; 2008 Oct; 29(10):1973-8. PubMed ID: 18684727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen receptor polymorphisms and the risk of endometrial cancer.
    Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
    BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
    De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
    Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meta-analysis of association between Arg326Gln (rs1503185) and Gln276Pro (rs1566734) polymorphisms of PTPRJ gene and cancer risk.
    Laczmanska I; Sasiadek MM
    J Appl Genet; 2019 Feb; 60(1):57-62. PubMed ID: 30661225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymorphisms in the vitamin D receptor gene and risk of lung cancer.
    Dogan I; Onen HI; Yurdakul AS; Konac E; Ozturk C; Varol A; Ekmekci A
    Med Sci Monit; 2009 Aug; 15(8):BR232-42. PubMed ID: 19644412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin resistance-related genes and advanced left-sided colorectal adenoma.
    Gunter MJ; Hayes RB; Chatterjee N; Yeager M; Welch R; Schoen RE; Yakochi L; Schatzkin A; Peters U
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):703-8. PubMed ID: 17416760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colorectal cancer susceptibility quantitative trait loci in mice as a novel approach to detect low-penetrance variants in humans: a two-stage case-control study.
    Fernández-Rozadilla C; Tarrío R; Clofent J; de Castro L; Brea-Fernández A; Bessa X; Abulí A; Andreu M; Jover R; Xicola R; Llor X; Castells A; Castellví-Bel S; Carracedo A; Ruiz-Ponte C;
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):619-23. PubMed ID: 20142256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
    Morita M; Le Marchand L; Kono S; Yin G; Toyomura K; Nagano J; Mizoue T; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Imaizumi N
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):235-41. PubMed ID: 19124503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk.
    Bethke L; Webb E; Sellick G; Rudd M; Penegar S; Withey L; Qureshi M; Houlston R
    BMC Cancer; 2007 Jul; 7():123. PubMed ID: 17615053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer.
    Sauter W; Rosenberger A; Beckmann L; Kropp S; Mittelstrass K; Timofeeva M; Wölke G; Steinwachs A; Scheiner D; Meese E; Sybrecht G; Kronenberg F; Dienemann H; ; Chang-Claude J; Illig T; Wichmann HE; Bickeböller H; Risch A
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1127-35. PubMed ID: 18483334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
    Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
    Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic variants in GTF2H1 and risk of lung cancer: a case-control analysis in a Chinese population.
    Wu W; Liu H; Lei R; Chen D; Zhang S; Lv J; Wang Y; Fan W; Qian J; Jin G; Ma H; Miao R; Hu Z; Wang H; Jin L; Wei Q; Shen H; Huang W; Lu D
    Lung Cancer; 2009 Feb; 63(2):180-6. PubMed ID: 18692935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymorphism in MHC class II transactivator gene is not associated with susceptibility to colorectal cancer in Swedish patients.
    Mumtaz M; Löfgren S; Hugander A; Dimberg J
    Anticancer Res; 2008; 28(3B):1789-91. PubMed ID: 18630461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical cancer in Korean women.
    Han SS; Cho EY; Lee TS; Kim JW; Park NH; Song YS; Kim JG; Lee HP; Kang SB
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):71-5. PubMed ID: 18367309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis.
    Xing J; Myers RE; He X; Qu F; Zhou F; Ma X; Hyslop T; Bao G; Wan S; Yang H; Chen Z
    Eur J Cancer; 2011 Jul; 47(11):1699-707. PubMed ID: 21402474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Haplotype-based analysis of common variation in the growth hormone receptor gene and prostate cancer risk.
    McKay JD; Kaaks R; Johansson M; Biessy C; Wiklund F; Bälter K; Adami HO; Boillot C; Gioia-Patricola L; Canzian F; Stattin P; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):169-73. PubMed ID: 17220348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.